Sopan Pharmaceuticals Limited (SOPL)
Manufacturing · Rs. 608.00 2.00 (+0.33%) as of Nov 6, 2026
Price — last 6 months
Full chart →Open
605.00
High / Low
611.00 / 605.00
Prev. close
606.00
Volume
12,724
52-week high
—
52-week low
—
Market cap
—
Shares outstanding
—
MASTER score
Mechanical 0–100 technical ranking. Methodology →
Promoter holding—
Public holding—
Stock performance
1-week change
-6.36%
1-month change
-3.80%
3-month change
-23.23%
6-month change
—
YTD change
—
1-year change
—
1-month high
689.00
1-month low
600.00
From 52-week high
—
From 52-week low
—
180-day avg price
747.68
360-day avg price
747.68
Avg volume (1w)
21,758
Avg volume (1m)
21,875
Avg volume (6m)
40,216
Avg volume (12m)
40,216
Daily volatility (1m)
2.78%
Beta vs NEPSE (1y)
2.09
Valuation
EPS (annualized)
—
EPS (TTM)
—
P/E
—
P/B
—
Book value / share
—
ROE
—
ROA
—
Net profit margin
—
Graham number
—
Dividend yield
—
Dividend
—
P/E and P/B use the latest close over per-share values from the company's most recent filed statement. Full dividend history →
Key indicators vs Manufacturing
EPS (Rs.)
N/A
min -6.29avg 452.86max 1,712.27
—
P/E
N/A
min 22.02avg 34.54max 48.82
—
P/B
N/A
min 2.29avg 5.08max 9.18
—
Networth / Share (Rs.)
N/A
min 98.04avg 1,518.08max 5,537.13
—
ROE (%)
N/A
min 0.00avg 10.89max 30.92
—
Technical indicators
| RSI (14) | 38.04 | Neutral |
| MACD | -22.23 | Bullish |
| EMA 5 | 614.63 | Bearish |
| EMA 20 | 634.22 | Bearish |
| EMA 180 | — | — |
| SMA 50 | 692.58 | Bearish |
| SMA 200 | — | — |
Pivot levels (classic)
S3
599.00S2
602.00S1
605.00PP
608.00R1
611.00R2
614.00R3
617.00Key financials — last 8 quarters
worsebetter vs same quarter last yearamounts in Rs · per-share in RsNo filed statements found.
More Manufacturing stocks
SOPL — frequently asked questions
What is Sopan Pharmaceuticals Limited's share price?
Rs. 608.00 as of Nov 6, 2026, the latest NEPSE trading session (+0.33% on the day).
What dividend did SOPL pay?
No dividend on record for the most recent fiscal year in our data.
Prices from the latest NEPSE session; fundamentals from the company's published quarterly statements. Research reference only — not investment advice.